NDC11 72611078502
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 72611-0785-02 | 72611-0785 |
| 72611-0785-2 | 72611-0785 |
| 72611-785-02 | 72611-785 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Temsirolimus | TEMSIROLIMUS INJECTION | Almaject, Inc. | a1f129ff-c0a4-ede7-ae9c-7a3cfa01fe12 | 2025-12-16 | Warnings, Adverse reactions | 72611-785-02 72611-785 72611078502 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.